Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 10 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Gender and tachycardia: independent modulation of platelet reactivity in patients with atrial fibrillationProcter, N.; Ball, J.; Ngo, D.; Isenberg, J.; Hylek, E.; Chirkov, Y.; Stewart, S.; Horowitz, J.
2015Impaired platelet nitric oxide response in patients with new onset atrial fibrillationProcter, N.; Ball, J.; Liu, S.; Hurst, N.; Nooney, V.; Goh, V.; Stafford, I.; Heresztyn, T.; Carrington, M.; Ngo, D.; Hylek, E.; Isenberg, J.; Chirkov, Y.; Stewart, S.; Horowitz, J.
2016New-onset atrial fibrillation and thromboembolic risk: Cardiovascular syzygy?Procter, N.; Stewart, S.; Horowitz, J.
2016Platelet hyperaggregability in patients with atrial fibrillation: Evidence of a background proinflammatory milieuProcter, N.; Ball, J.; Ngo, D.; Chirkov, Y.; Isenberg, J.; Hylek, E.; Stewart, S.; Horowitz, J.
2015Suppression of neutrophil superoxide generation by BNP is attenuated in acute heart failure: a case for 'BNP resistance'Liu, S.; Ngo, D.; Chong, C.; Amarasekera, A.; Procter, N.; Licari, G.; Dautov, R.; Stewart, S.; Chirkov, Y.; Horowitz, J.
2013Reciprocal regulation of NO signaling and TXNIP expression in humans: Impact of aging and ramipril therapySverdlov, A.; Chan, W.; Procter, N.; Chirkov, Y.; Ngo, D.; Horowitz, J.
2014Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetesChong, C.; Chan, W.; Nguyen, T.; Liu, S.; Procter, N.; Ngo, D.; Sverdlov, A.; Chirkov, Y.; Horowitz, J.
2016Platelet reactivity is independent of left atrial wall deformation in patients with atrial fibrillationProcter, N.; Goh, V.; Mahadevan, G.; Stewart, S.; Horowitz, J.
2014Aging of platelet nitric oxide signaling: pathogenesis, clinical implications, and therapeuticsProcter, N.; Chong, C.; Sverdlov, A.; Chan, W.; Chirkov, Y.; Horowitz, J.
2012Ramipril sensitizes platelets to nitric oxide: Implications for therapy in high-risk patientsWilloughby, S.; Rajendran, S.; Chan, W.; Procter, N.; Leslie, S.; Liberts, E.; Heresztyn, T.; Chirkov, Y.; Horowitz, J.